Key Role of DAMP in Inflammation, Cancer, and Tissue Repair.

[1]  T. Theoharides,et al.  Mast cells, brain inflammation and autism. , 2016, European journal of pharmacology.

[2]  I. Barberi,et al.  Visfatin: New marker of oxidative stress in preterm newborns , 2016, International journal of immunopathology and pharmacology.

[3]  S. Maier,et al.  The danger-associated molecular pattern HMGB1 mediates the neuroinflammatory effects of methamphetamine , 2016, Brain, Behavior, and Immunity.

[4]  M. Lotze,et al.  DAMPs, ageing, and cancer: The ‘DAMP Hypothesis’ , 2015, Ageing Research Reviews.

[5]  Hoguen Kim,et al.  Combined targeting of high‐mobility group box‐1 and interleukin‐8 to control micrometastasis potential in gastric cancer , 2015, International journal of cancer.

[6]  P. Souček,et al.  Role of family D ATP-binding cassette transporters (ABCD) in cancer. , 2015, Biochemical Society transactions.

[7]  K. Ashkan,et al.  Mast cells in meningiomas and brain inflammation , 2015, Journal of Neuroinflammation.

[8]  P. Agostinis,et al.  Immunogenic cell death. , 2015, The International journal of developmental biology.

[9]  M. Riquelme,et al.  ATP, a double-edged sword in cancer , 2015, Oncoscience.

[10]  M. Bianchi,et al.  DAMPs from Cell Death to New Life , 2015, Front. Immunol..

[11]  K. Natarajan,et al.  Pattern Recognition Receptors in Cancer Progression and Metastasis , 2015, Cancer growth and metastasis.

[12]  Y. Mao,et al.  HoxB7 PROMOTES GROWTH AND METASTASIS OF LUNG ADENOCARCINOMA CELLS THROUGH REGULATION OF THE TGF-β/SMAD3 SIGNALING. , 2015, Journal of biological regulators and homeostatic agents.

[13]  H. Qiu,et al.  REPAIR EFFECTS OF UMBILICAL CORD MESENCHYMAL STEM CELLS ON PODOCYTE DAMAGE OF IgA NEPHROPATHY. , 2015, Journal of biological regulators and homeostatic agents.

[14]  A. Caraffa,et al.  IMMUNOMODULATORY EFFECTS OF VITAMIN D ON SKIN INFLAMMATION. , 2015, Journal of biological regulators and homeostatic agents.

[15]  C. Lei,et al.  HMGB1 may act via RAGE to promote angiogenesis in the later phase after intracerebral hemorrhage , 2015, Neuroscience.

[16]  G. Gambassi,et al.  How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology , 2015, Journal of immunology research.

[17]  S. Akira,et al.  Toll‐Like Receptors , 2015, Current protocols in immunology.

[18]  S. Leonardi,et al.  CHILDHOOD IDIOPATHIC NEPHROTIC SYNDROME AND ATOPIC DISEASES: IS THERE A RELATIONSHIP? , 2015, Journal of biological regulators and homeostatic agents.

[19]  S. Tanuma,et al.  Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1β, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death. , 2015, Biochemical and biophysical research communications.

[20]  Cang Liu,et al.  Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells. , 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[21]  I. Yano,et al.  Extracellular nucleotides from dying cells act as molecular signals to promote wound repair in renal tubular injury. , 2014, American journal of physiology. Renal physiology.

[22]  Hyuk-Jae Chang,et al.  Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats , 2014, Respiratory Research.

[23]  M. Zhu,et al.  Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis. , 2014, International journal of clinical and experimental pathology.

[24]  Dominik Rünzler,et al.  Shock Wave Treatment Enhances Cell Proliferation and Improves Wound Healing by ATP Release-coupled Extracellular Signal-regulated Kinase (ERK) Activation* , 2014, The Journal of Biological Chemistry.

[25]  Yunhua Deng,et al.  Effects of high mobility group protein box 1 and toll like receptor 4 pathway on warts caused by human papillomavirus , 2014, Molecular medicine reports.

[26]  S. Awasthi,et al.  Toll-Like Receptor-4 Modulation for Cancer Immunotherapy , 2014, Front. Immunol..

[27]  G. Stacey,et al.  Extracellular ATP acts as a damage-associated molecular pattern (DAMP) signal in plants , 2014, Front. Plant Sci..

[28]  T. Zhao,et al.  AB124. Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer , 2014, American journal of cancer research.

[29]  R. Schwabe,et al.  The Yin and Yang of Toll-like receptors in cancer , 2014, Oncogene.

[30]  Jae Heun Lee,et al.  P2Y2R activation by nucleotides promotes skin wound‐healing process , 2014, Experimental dermatology.

[31]  A. MacLeod,et al.  Skin-Resident T Cells Sense Ultraviolet Radiation–Induced Injury and Contribute to DNA Repair , 2014, The Journal of Immunology.

[32]  M. Bianchi,et al.  Leukocyte HMGB1 Is Required for Vessel Remodeling in Regenerating Muscles , 2014, The Journal of Immunology.

[33]  K. Tracey,et al.  Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review , 2014, Expert review of clinical immunology.

[34]  M. Idzko,et al.  Nucleotide signalling during inflammation , 2014, Nature.

[35]  Harshini Sarojini,et al.  Rapid Granulation Tissue Regeneration by Intracellular ATP Delivery-A Comparison with Regranex , 2014, PloS one.

[36]  D. Musumeci,et al.  An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. , 2014, Pharmacology & therapeutics.

[37]  H. Niu,et al.  Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[38]  Xiaohong Zhang,et al.  Expression of HMGB1 and NF-κB p65 and its significance in non-small cell lung cancer , 2013, Contemporary oncology.

[39]  Lisong Shen,et al.  Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production , 2013, Cell Death and Disease.

[40]  E. Tzeng,et al.  HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia. , 2013, Journal of vascular surgery.

[41]  L. Zitvogel,et al.  Molecular mechanisms of ATP secretion during immunogenic cell death , 2013, Cell Death and Differentiation.

[42]  C. Sarafoleanu,et al.  Are HMGB1 protein expression and secretion markers of upper airways inflammatory diseases? , 2013, Journal of biological regulators and homeostatic agents.

[43]  Yunhua Deng,et al.  Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors , 2013, BMC Cancer.

[44]  R. Lukaszewski,et al.  Targeting the “Rising DAMP” during a Francisella tularensis Infection , 2013, Antimicrobial Agents and Chemotherapy.

[45]  T. Kanda,et al.  Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: Possible implication for TLR4-signalling and chronic immune activation , 2013, Innate immunity.

[46]  Lin Liu,et al.  [Expression and clinical significance of TLR2 in laryngeal carcinoma tissue]. , 2013, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.

[47]  M. Lotze,et al.  HMGB1 in Cancer: Good, Bad, or Both? , 2013, Clinical Cancer Research.

[48]  B. Yan,et al.  TLR4 Ligand/H2O2 Enhances TGF-β1 Signaling to Induce Metastatic Potential of Non-Invasive Breast Cancer Cells by Activating Non-Smad Pathways , 2013, PloS one.

[49]  C.‐Y. Li,et al.  Toll-like receptor 4 genetic variants and prognosis of breast cancer. , 2013, Tissue antigens.

[50]  Kui Zhang,et al.  The TLR4 gene polymorphisms and susceptibility to cancer: a systematic review and meta-analysis. , 2013, European journal of cancer.

[51]  W A Buurman,et al.  Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1 , 2013, Oncogene.

[52]  I. Couillin,et al.  ATP release and purinergic signaling in NLRP3 inflammasome activation , 2013, Front. Immun..

[53]  M. Sitkovsky,et al.  Purinergic signaling during inflammation. , 2012, The New England journal of medicine.

[54]  H. Westerblad,et al.  TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis , 2012, Annals of the rheumatic diseases.

[55]  Atsuo Ochi,et al.  Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. , 2012, The Journal of clinical investigation.

[56]  H. Weng,et al.  Ethyl Pyruvate Administration Suppresses Growth and Invasion of Gallbladder Cancer Cells via Downregulation of Hmgb1-Rage Axis , 2012, International journal of immunopathology and pharmacology.

[57]  Ja-Kyeong Lee,et al.  Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain , 2012, Neuroscience Letters.

[58]  Atsuo Ochi,et al.  MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells , 2012, The Journal of experimental medicine.

[59]  H. Pass,et al.  Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. , 2012, Cancer research.

[60]  A. Barbul,et al.  Role of high mobility group box 1 (HMGB1) in wound healing. , 2012, The Journal of surgical research.

[61]  A. Sönnerborg,et al.  Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection , 2012, International journal of microbiology.

[62]  J. Wehkamp,et al.  Innate immune dysfunction in inflammatory bowel disease , 2012, Journal of internal medicine.

[63]  Raul Rabadan,et al.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.

[64]  P. Han,et al.  Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion , 2012, Neurobiology of Disease.

[65]  P. Vandenabeele,et al.  A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death , 2012, The EMBO journal.

[66]  K. Tracey,et al.  Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis , 2012, Arthritis Research & Therapy.

[67]  Il-Doo Kim,et al.  Formation of a polymer particle monolayer by continuous self-assembly from a colloidal solution. , 2012, Journal of colloid and interface science.

[68]  D. Pagliari,et al.  The Immune Response to Tumors as a Tool toward Immunotherapy , 2011, Clinical & developmental immunology.

[69]  R. Jerala,et al.  Toll-Like Receptor 4 Activation in Cancer Progression and Therapy , 2011, Clinical & developmental immunology.

[70]  M. Gougeon,et al.  HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells , 2011, Cell Death and Differentiation.

[71]  Zuqiang Liu,et al.  Knockdown of HMGB1 in Tumor Cells Attenuates Their Ability To Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-Dependent Antitumor Immunity , 2011, The Journal of Immunology.

[72]  Michele De Palma,et al.  The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. , 2011, The International journal of developmental biology.

[73]  S. Brandt,et al.  Induction of TLR-2 and TLR-5 Expression by Helicobacter pylori Switches cagPAI-Dependent Signalling Leading to the Secretion of IL-8 and TNF-α , 2011, PloS one.

[74]  X. Yao,et al.  High-Mobility Group Box-1 Mediates Toll-Like Receptor 4–Dependent Angiogenesis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[75]  Y. Kaneda,et al.  PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia , 2011, Proceedings of the National Academy of Sciences.

[76]  G. Di Sante,et al.  Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases. , 2011, Journal of biological regulators and homeostatic agents.

[77]  K. Tracey,et al.  HMGB1 is a therapeutic target for sterile inflammation and infection. , 2011, Annual review of immunology.

[78]  W. Junger,et al.  Immune cell regulation by autocrine purinergic signalling , 2011, Nature Reviews Immunology.

[79]  Jau-Shyong Hong,et al.  HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration , 2011, The Journal of Neuroscience.

[80]  E. Solary,et al.  Transactivation of the Epidermal Growth Factor Receptor by Heat Shock Protein 90 via Toll-like Receptor 4 Contributes to the Migration of Glioblastoma Cells* , 2010, The Journal of Biological Chemistry.

[81]  M. Gavala,et al.  Extracellular ATP May Contribute to Tissue Repair by Rapidly Stimulating Purinergic Receptor X7-Dependent Vascular Endothelial Growth Factor Release from Primary Human Monocytes , 2010, The Journal of Immunology.

[82]  K. Ravichandran.  Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums , 2010, The Journal of experimental medicine.

[83]  Christiana Ruhrberg,et al.  Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. , 2010, Blood.

[84]  K. Midwood,et al.  DAMPening Inflammation by Modulating TLR Signalling , 2010, Mediators of inflammation.

[85]  A. Coyle,et al.  HMGB1 and RAGE in inflammation and cancer. , 2010, Annual review of immunology.

[86]  G. Ghirlanda,et al.  High-Mobility Group Box-1 Protein Promotes Angiogenesis After Peripheral Ischemia in Diabetic Mice Through a VEGF-Dependent Mechanism , 2010, Diabetes.

[87]  Y. Yamashita,et al.  HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer. , 2010, European journal of cancer.

[88]  K. Riesbeck,et al.  Toll‐like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas , 2009, Immunology.

[89]  D. Foell,et al.  The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer , 2009, Journal of leukocyte biology.

[90]  B. Burlando,et al.  HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation , 2009, Molecular and Cellular Biochemistry.

[91]  Yongheng Chen,et al.  Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. , 2009, Lung cancer.

[92]  K. Tracey,et al.  The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage , 2008, The Journal of Neuroscience.

[93]  D. Morton,et al.  Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors , 2008, Molecular Cancer Therapeutics.

[94]  I. Kubota,et al.  High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. , 2008, Cardiovascular research.

[95]  N. Zhong,et al.  Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[96]  M. Capogrossi,et al.  High-mobility group box 1 protein in human and murine skin: involvement in wound healing. , 2008, The Journal of investigative dermatology.

[97]  G. Weisman,et al.  Binding of the P2Y2 Nucleotide Receptor to Filamin A Regulates Migration of Vascular Smooth Muscle Cells , 2008, Circulation research.

[98]  M. Abreu,et al.  Role of Toll-like receptors in gastrointestinal malignancies , 2008, Oncogene.

[99]  T. Yoshino,et al.  Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[100]  R. Xu,et al.  Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. , 2007, Gastroenterology.

[101]  M. Rosengart,et al.  HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling , 2007, The Journal of experimental medicine.

[102]  M. Capogrossi,et al.  Multiple Effects of High Mobility Group Box Protein 1 in Skeletal Muscle Regeneration , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[103]  M. Omata,et al.  Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. , 2007, Biochemical and biophysical research communications.

[104]  Nan Li,et al.  TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. , 2007, Molecular immunology.

[105]  A. Krieg.  Toll-free vaccines? , 2007, Nature Biotechnology.

[106]  E. Chavakis,et al.  High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells , 2007, Circulation research.

[107]  Y. Takeyama,et al.  Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. , 2006, World journal of gastroenterology.

[108]  A. Griffioen,et al.  Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature. , 2006, Blood.

[109]  K. Tracey,et al.  Anti-HMGB1 Neutralizing Antibody Ameliorates Gut Barrier Dysfunction and Improves Survival after Hemorrhagic Shock , 2006, Molecular medicine.

[110]  C. Dinarello.  Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. , 2006, The American journal of clinical nutrition.

[111]  M. Presta,et al.  Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine1 , 2006, The Journal of Immunology.

[112]  Jaw-Town Lin,et al.  Helicobacter pylori-Induced Invasion and Angiogenesis of Gastric Cells Is Mediated by Cyclooxygenase-2 Induction through TLR2/TLR9 and Promoter Regulation1 , 2005, The Journal of Immunology.

[113]  M. Bianchi,et al.  HMG proteins: dynamic players in gene regulation and differentiation. , 2005, Current opinion in genetics & development.

[114]  P. Rogalla,et al.  Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. , 2005, The American journal of pathology.

[115]  V. Trinkaus-Randall,et al.  Modulation of endothelial cell migration by extracellular nucleotides , 2005, Thrombosis and Haemostasis.

[116]  W. Scovell,et al.  High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity. , 2004, Molecular Endocrinology.

[117]  K. Tracey,et al.  High Mobility Group Box Protein 1: An Endogenous Signal for Dendritic Cell Maturation and Th1 Polarization , 2004, The Journal of Immunology.

[118]  R. Donato,et al.  Amphoterin Stimulates Myogenesis and Counteracts the Antimyogenic Factors Basic Fibroblast Growth Factor and S100B via RAGE Binding , 2004, Molecular and Cellular Biology.

[119]  T. Sasahira,et al.  Depletion of Tumor-Infiltrating Macrophages Is Associated with Amphoterin Expression in Colon Cancer , 2004, Pathobiology.

[120]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[121]  M. Bianchi,et al.  Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation , 2004, The Journal of cell biology.

[122]  Stefan Joos,et al.  HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[123]  U. Andersson,et al.  High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. , 2003, Arthritis and rheumatism.

[124]  Hoguen Kim,et al.  Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. , 2003, Cancer research.

[125]  B. Marino,et al.  Biased T‐cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) , 2003, Clinical and experimental immunology.

[126]  T. Yamashita,et al.  Detection and Induction of CTLs Specific for SYT-SSX-Derived Peptides in HLA-A24+ Patients with Synovial Sarcoma1 , 2002, The Journal of Immunology.

[127]  S. Müller,et al.  The High Mobility Group (Hmg) Boxes of the Nuclear Protein Hmg1 Induce Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells , 2001, The Journal of cell biology.

[128]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[129]  J. Brickman,et al.  Interactions between an HMG-1 protein and members of the Rel family. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[130]  A. Singer,et al.  Cutaneous wound healing. , 1999, The New England journal of medicine.

[131]  Hishii,et al.  Studies of the mechanism of cytolysis by tumour‐infiltrating lymphocytes , 1999, Clinical and experimental immunology.

[132]  A. Farrelly,et al.  Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells. , 1999, American journal of physiology. Heart and circulatory physiology.

[133]  J. Boyle,et al.  Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen‐activated protein kinase , 1997, British journal of pharmacology.

[134]  A. Boyajyan,et al.  Transcriptional activity of neutrophils exposed to high doses of colchicine: short communication. , 2015, Journal of biological regulators and homeostatic agents.

[135]  C. Svensson,et al.  Role of extracellular damage-associated molecular pattern molecules (DAMPs) as mediators of persistent pain. , 2015, Progress in molecular biology and translational science.

[136]  E. Della Bella,et al.  BIOPHYSICAL STIMULATION FOR NONUNIONS. , 2015, Journal of biological regulators and homeostatic agents.

[137]  A. Boyajyan,et al.  VITAMIN D AND BRONCHIAL INFLAMMATION IN ASTHMATIC CHILDREN. , 2015 .

[138]  M. Lotze,et al.  Targeting damage-associated molecular pattern molecules (DAMPs) and DAMP receptors in melanoma. , 2014, Methods in molecular biology.

[139]  H. Zhu,et al.  Targeting HMGB1 inhibits bladder cancer cells bioactivity by lentivirus-mediated RNA interference. , 2014, Neoplasma.

[140]  G. d’Annunzio.  IMPACT OF MAST CELLS ON MULTIPLE SCLEROSIS: INHIBITORY EFFECT OF NATALIZUMAB , 2014 .

[141]  P. Fasanaro,et al.  Transcriptional Profiling of Hmgb1-Induced Myocardial Repair Identifies a Key Role for Notch Signaling. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[142]  M. Schachner,et al.  HMGB1 Contributes to Regeneration After Spinal Cord Injury in Adult Zebrafish , 2013, Molecular Neurobiology.

[143]  C. Baty,et al.  High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury. , 2012, Journal of vascular surgery.

[144]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2010, Nature.

[145]  Herbert J Zeh,et al.  High-mobility group box 1 and cancer. , 2010, Biochimica et biophysica acta.

[146]  D. Samuel,et al.  ATP release after partial hepatectomy regulates liver regeneration in the rat. , 2010, Journal of hepatology.

[147]  M. Bianchi,et al.  Regulation of dendritic- and T-cell fate by injury-associated endogenous signals. , 2009, Critical reviews in immunology.

[148]  A. Fiszer-Kierzkowska,et al.  Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma. , 2008, Anticancer research.

[149]  M. Lind,et al.  Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer. , 2006, Oncology reports.

[150]  D. Avidandrews,et al.  In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites , 1997 .